The STING pathway is often inhibited by gliomas through the reduced expression of key components such as cGAS and STING, leading to impaired detection of tumor-derived DNA and lowered production of type I IFN, found to be essential in triggering tumor suppressive responses [132]. This evidence concerns the gene STING1 and neoplasm.